Actualizaciones regulatorias

Sun Pharm Industries' quinidine sulfate tablet (200 mg) received FDA approval under ANDA081030, with manufacturing and labeling submissions approved between 1989 and 2010. The product is currently listed as discontinued.

Sun Pharm Industries received FDA approval for an ANDA (ANDA081029) covering oral quinidine sulfate tablets (100 mg). The product is listed as discontinued, with multiple supplemental approvals for manufacturing and labeling.

The FDA granted approval for SUN PHARM INDUSTRIES' ANDA080699 covering oral Meprobamate tablets (200 mg and 400 mg). Multiple manufacturing and labeling submissions were approved between 1986 and 1998; the products are now discontinued.